Aktualności
FDA: Guidance for Industry - Annex 2 Test for Extractable Volume of Parenteral Preparations General Chapter
30.01.2009
FDA:
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 2 Test for Extractable Volume of Parenteral Preparations General ...
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 2 Test for Extractable Volume of Parenteral Preparations General ...
FDA: Guidance for Industry - Annex 3 Test for Particulate Contamination: Subvisible Particles General Chapter
30.01.2009
FDA:
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 3 Test for Particulate Contamination: Subvisible Particles General ...
Guidance for Industry - Q4B Evaluation and Recommendation of Pharmacopoeial Texts for Use in the ICH Regions. Annex 3 Test for Particulate Contamination: Subvisible Particles General ...
FDA: Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft)
30.01.2009
FDA:
Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft). In this guidance, FDA is ...
Guidance for Industry - Standards for Securing the Drug Supply Chain - Standardized Numerical Identification for Prescription Drug Packages (draft). In this guidance, FDA is ...
MHRA: Guidance on writing patient information leaflets
MHRA has developed specific guidance on writing patient information leaflets (PILs). ...
How CMDh helps Marketing Authorisation Holders (MAHs) to facilitate regulatory procedures during the COVID-19 crisis?
The SARS-CoV-2 virus pandemic has undoubtedly affected various areas of our lives, not only our private lives and interpersonal contacts, but it has also firmly affected the areas of lives
...
